Showing results (1-10 of 372) with videos related to
Sort By:
Pageof 38
Seminars in Urologic Oncology|December 19, 2002
Chemotherapy for good-risk germ-cell tumorsCharles J Ryan, Dean F BajorinClinical Genitourinary Cancer|October 10, 2009
Arsenic trioxide in recurrent urothelial cancer: a cancer and leukemia group B phase II trial (CALGB 99903)Dean F Bajorin, Susan Halabi, Eric SmallExpert Review of Anticancer Therapy|November 30, 2010
Novel strategies for treating relapsed/refractory urothelial carcinomaGopa Iyer, Matthew I Milowsky, Dean F BajorinNature Reviews. Urology|April 13, 2010
False elevation of human chorionic gonadotropin in a patient with testicular cancerDavid J Gallagher, Jamie Riches, Dean F BajorinHematology/Oncology Clinics of North America|April 4, 2015
First-line treatment and prognostic factors of metastatic bladder cancer for platinum-eligible patientsWassim Abida, Dean F Bajorin, Jonathan E RosenbergTherapeutic Advances in Urology|September 10, 2011
Management of invasive bladder cancer in patients who are not candidates for or decline cystectomyArjun Balar, Dean F Bajorin, Matthew I MilowskyFuture Oncology (London, England)|October 2, 2009
Clinical states model for biomarkers in bladder cancerAndrea B Apolo, Matthew Milowsky, Dean F BajorinCancer|July 17, 2008
Advanced bladder cancer: status of first-line chemotherapy and the search for active agents in the second-line settingDavid J Gallagher, Matthew I Milowsky, Dean F BajorinBJU International|November 28, 2008
Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancerMatthew I Milowsky, Walter M Stadler, Dean F BajorinThe Journal of Urology|January 16, 2007
Defining optimal therapy for muscle invasive bladder cancerHarry W Herr, Zohar Dotan, S Machele Donat, et al.Pageof 38